Skip to main content
Log in

Celiac Disease and Non-organ-specific Autoantibodies in Patients with Chronic Hepatitis C Virus Infection

  • Original Paper
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Objective Considering that celiac disease (CD) is an autoimmune-based entity and the hepatitis C virus is suspected of being able to trigging autoimmune reactions, it has been hypothesized that hepatitis C virus infection might predispose to CD. The aim of this study was to investigate CD-related antibodies in a large series of hepatitis C virus-infected subjects that were also tested for non-organ-specific autoantibodies (NOSA) as indirect marker of autoimmune disorders. Methods Two hundred and forty-four patients with chronic hepatitis C virus infection (HCV-patients) and 121 patients with HCV-negative liver disease (non-HCV-patients) underwent NOSA determination and celiac serology (firstly, anti-tissue transglutaminase antibodies, then the cases which tested positive were subsequently evaluated for the presence of antiendomysial antibodies). Serum samples from 42 of the HCV-patients who underwent interferon-alpha therapy after enrolment were tested for celiac antibodies and NOSA even after stopping treatment. Additionally, sera from 1,230 blood donors were assayed for celiac serology as healthy control population. Results Positive anti-endomysial antibodies (AEA) were found in 5/244 (2%) HCV-patients, 1/121 (0.8%) non-HCV-patients and 2/1,230 (0.16%) blood donors, with a significant difference between HCV-patients and blood donors (P = 0.02; Odds ratio 12.8; 95% Confidence Interval 2.4–66). NOSA were found in 51 HCV-patients but only one of them had positive AEA. Eight out of 42 HCV-patients treated with interferon-alpha developed NOSA under therapy and none of them had CD antibodies. Conclusions AEA occur in 2% of HCV-patients and their presence is independent of other patterns of autoimmunity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Kagnoff MF (2005) Overview and pathogenesis of celiac disease. Gastroenterology 128(4 Suppl 1):S10–S18

    Article  PubMed  CAS  Google Scholar 

  2. Volta U, De Franceschi L, Molinaro N et al (1998) Frequency and significance of anti-gliadin and anti-endomysial antibodies in autoimmune hepatitis. Dig Dis Sci 43:2190–2195

    Article  PubMed  CAS  Google Scholar 

  3. Dickey W, McMillan SA, Callender ME (1997) High prevalence of celiac sprue among patients with primary biliary cirrhosis. J Clin Gastroenterol 25:328–329

    Article  PubMed  CAS  Google Scholar 

  4. Kingham JG, Parker DR (1998) The association between primary biliary cirrhosis and celiac disease: a study of relative prevalences. Gut 42:120–122

    PubMed  CAS  Google Scholar 

  5. Floreani A, Betterle C, Baragiotto A et al (2002) Prevalence of coeliac disease in primary biliary cirrhosis and of antimitochondrial antibodies in adult coeliac disease patients in Italy. Dig Liver Dis 34:258–261

    Article  PubMed  CAS  Google Scholar 

  6. Volta U, Rodrigo L, Granito A et al (2002) Celiac disease in autoimmune cholestatic liver disorders. Am J Gastroenterol 97:2609–2613

    Article  PubMed  Google Scholar 

  7. Volta U, De Franceschi L, Lari F et al (1998) Coeliac disease hidden by cryptogenic hypertransaminasaemia. Lancet 35:26–29

    Article  Google Scholar 

  8. Bardella MT, Vecchi M, Conte D et al (1999) Chronic unexplained hypertransaminasemia may be caused by occult celiac disease. Hepatology 29:654–657

    Article  PubMed  CAS  Google Scholar 

  9. Lo Iacono O, Petta S, Venezia G et al (2005) Anti-tissue transglutaminase antibodies in patients with abnormal liver tests: is it always celiac disease? Am J Gastroenterol 100:2472–2477

    Article  PubMed  CAS  Google Scholar 

  10. Fine KD, Ogunji F, Saloum Y et al (2001) Celiac Sprue: another autoimmune Syndrome associated with hepatitis C. Am J Gastroenterol 96:138–145

    Article  PubMed  CAS  Google Scholar 

  11. Bardella MT, Marino R, Meroni PL (1999) Celiac disease during interferon treatment. Ann Intern Med 131:157–158

    PubMed  CAS  Google Scholar 

  12. Cammarota G, Cuoco L, Pandolfi F et al (2000) Onset of coeliac disease during treatment with interferon for chronic hepatitis C. Lancet 356:1494–1495

    Article  PubMed  CAS  Google Scholar 

  13. Adinolfi LE, Durante-Mangoni E, Andreana A (2001) Interferon and ribavirin treatment for chronic hepatitis C may activate celiac disease. Am J Gastroenterol 96:607–608

    Article  PubMed  CAS  Google Scholar 

  14. Bourliere M, Oules V, Perrier H et al (2001) Onset of coeliac disease and interferon treatment. Lancet 357:803–804

    Article  PubMed  CAS  Google Scholar 

  15. Narvaez I, Perez B, del Mar Alcade M et al (2003) Chronic viral hepatitis, interferon, diabetes mellitus, and celiac disease. Am J Gastroenterol 98:2336–2337

    Article  PubMed  Google Scholar 

  16. Durante-Mangoni E, Iardino P, Resse M et al (2004) Silent celiac disease in chronic hepatitis C: impact of interferon treatment on the disease onset and clinical outcome. J Clin Gastroenterol 38:901–905

    Article  PubMed  CAS  Google Scholar 

  17. Martins EV Jr, Gaburri AK (2004) Celiac disease onset after pegylated interferon and ribavirin treatment of chronic hepatitis C. Arq Gastroenterol 4:132–133

    Google Scholar 

  18. Scoglio R, Di Pasquale G, Pagano G et al (2003) Is intestinal biopsy always needed for diagnosis of celiac disease? Am J Gastroenterol 98:1325–1331

    Article  PubMed  Google Scholar 

  19. Not T, Horvath K, Hill ID et al (1998) Celiac disease risk in the USA: high prevalence of antiendomysium antibodies in healthy blood donors. Scand J Gastroenterol 33:494–498

    Article  PubMed  CAS  Google Scholar 

  20. Squadrito G, Previti M, Lenzi M et al (2003) High prevalence of non-organ-specific autoantibodies in hepatitis C virus infected cirrhotic patients from southern Italy. Dig Dis Sci 48:349–353

    Article  PubMed  Google Scholar 

  21. Sagnelli E, Stroffolini T, Almasio P et al (2005) The relevance of hepatitis C virus infection in the burden of chronic liver disease in Italy. J Med Virol 75:525–527

    Google Scholar 

  22. Trevisiol C, Not T, Berti I et al (1999) Screening for coeliac disease in healthy blood donors at two immuno-transfusion centres in north-east Italy. Ital J Gastroenterol Hepatol 31:584–586

    PubMed  CAS  Google Scholar 

  23. Vogelsang H, Genser D, Wyatt J et al (1995) Screening for celiac disease: a prospective study on the value of non invasive tests. Am J Gastroenterol 90:394–398

    PubMed  CAS  Google Scholar 

  24. Carroccio A, Iacono G, Montalto G et al (1993) Immunologic and absorptive tests in celiac disease: can they replace intestinal biopsies? Scand J Gastroenterol 28:673–676

    Article  PubMed  CAS  Google Scholar 

  25. Corazza GR, Andreani ML, Biagi F et al (1997) The smaller size of the ‘coeliac iceberg’ in adults. Scand J Gastroenterol 32:917–919

    Article  PubMed  CAS  Google Scholar 

  26. Johnson RJ, Gretch DR, Yamabe H et al (1993) Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Engl J Med 328:465–470

    Article  PubMed  CAS  Google Scholar 

  27. Tran A, Quaranta JF, Benzanken S et al (1993) High prevalence of thyroid autoantibodies in a prospective series of patients with chronic hepatitis C before interferon therapy. Hepatology 18:253–257

    PubMed  CAS  Google Scholar 

  28. Lunel F, Musset L, Cacoub P et al (1994) Cryoglobulinemia in chronic liver disease: role of hepatitis C virus and liver damage. Gastroenterology 106:1291–1300

    PubMed  CAS  Google Scholar 

  29. Adinolfi LE, Utili R, Attanasio V et al (1996) Epidemiology, clinical spectrum and prognostic value of mixed cryoglobulinemia in hepatitis C virus patients. A prospective study. Ital J Gastroenterol 28:1–9

    PubMed  CAS  Google Scholar 

  30. Obermayer-Straub P, Manns MP (2001) Heapatitis C and D, retroviruses and autoimmune manifestations. J Autoimm 16:275–285

    Article  CAS  Google Scholar 

  31. Lenzi M, Bellentani S, Saccoccio G et al (1999) Prevelance of non-organ-specific autoantibodies and chronic liver disease in the general population: a nested-case-control study of the Dyonysos cohort. GUT 45:435–441

    Article  PubMed  CAS  Google Scholar 

  32. Davison S (2002) Celiac disease and liver dysfunction. Arch Dis Child 87:293–296

    Article  PubMed  CAS  Google Scholar 

  33. McKiernan SM, Hagan R, Curry M et al (2004) MHC class I and II alleles are associated with hepatitis C viral clearance, originating from a single source. Hepatology 40:108–114

    Article  PubMed  CAS  Google Scholar 

  34. Chiang BL, Yang PM, Hwang LH et al (1998) Establishment and characterization of NS3 protein specific T-cell clones from a patient with chronic hepatitis C. J Biomed Sci 5:290–296

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgment

Dedicated to the memory of Professor Giuseppe Di Pasquale.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Giuseppe Magazzù.

Additional information

C. Ruggeri and A. T. La Masa equally contributed to this work.

G. Di Pasquale passed away on June 2006.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ruggeri, C., La Masa, A.T., Rudi, S. et al. Celiac Disease and Non-organ-specific Autoantibodies in Patients with Chronic Hepatitis C Virus Infection. Dig Dis Sci 53, 2151–2155 (2008). https://doi.org/10.1007/s10620-007-0146-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-007-0146-1

Keywords

Navigation